Goldenwell Biotech, Inc. (GWLL)
OQB · Consumer Defensive · Packaged Foods
$0.90
+0.00%
Closing price as of 2026-07-28 · Source: TEK2day Finance
Key Metrics
Market Cap
$89.1M
Shares Outstanding
99.0M
P/S (TTM)
1,424x
Exchange
OQB
Currency
USD
About Goldenwell Biotech, Inc.
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Hudson, Ohio.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 38K | 25K | 55.00 | 0.00 |
| Gross Profit | 38K | 25K | 12.00 | 0.00 |
| Operating Income | -3K | -6K | -23K | -31K |
| Net Income | -5K | -8K | -200K | -18K |
| Diluted EPS | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 48K | 2K | 139.00 | 55.00 |
| Gross Profit | 25K | 666.00 | 64.00 | 12.00 |
| Operating Income | -985K | -116K | -123K | -113K |
| Net Income | -985K | -117K | -131K | -296K |
| Diluted EPS | $-0.01 | $0.00 | $0.00 | $-0.00 |